Oriana Papin-Zoghbi is the co-founder of a women’s health startup called AOA Dx that is working towards early detection for ovarian cancer. Oriana talks about the challenges the company has faced in navigating the complex world of fundraising, the term ‘femtech’, and the experience of leading a startup dedicated to transforming women's health.
Want to find out what's coming next on Overlooked, or learn about the backstory to the episodes? Sign up to the email list to get updates from Golda at www.overlookedpod.com.
SHOW NOTES:
Links for further learning:
AOA Dx and their new lab in Denver: https://www.linkedin.com/company/aoadx/
More on gangliosides / Professor Uri Saragovi's work: https://pubmed.ncbi.nlm.nih.gov/37124505/
The origins of the term ‘Femtech’ : https://www.cnbc.com/2023/03/06/meet-the-woman-who-invented-a-whole-new-subsection-of-tech-set-to-be-worth-1-trillion.html
DISCLAIMER:
What you hear and read on ‘Overlooked’ is for general information purposes only and represents the opinions of the host and guests. The content on the podcast and website should not be taken as medical advice. Every person’s body is unique, so please consult your healthcare professional for any medical questions that may arise.